文献速递自身炎症与 IgG4 相关病

多组学分析揭示STAT1为甲羟戊酸激酶缺乏症的潜在修饰基因

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency.
PubMed 文献 · Ann Rheum Dis · 2018-07-20

研究通过外显子组、转录组和蛋白质组多组学分析,解释同一家系中两名携带相同高IgD综合征纯合致病突变同胞的表型差异。结果发现STAT1罕见错义变异在症状同胞中mRNA和蛋白显著过表达,且为功能获得性变异,参与JAK/STAT通路激活。研究展示多组学方法发现潜在可干预靶点用于个体化治疗的能力。

要点

  • 两名同胞携带相同高IgD综合征纯合致病突变却表型相反,一例无症状、一例表现全部经典型特征。
  • 多组学分析识别出STAT1罕见错义变异,症状同胞较无症状同胞mRNA和蛋白显著过表达。
  • 该STAT1变异为功能获得性,参与JAK/STAT通路激活增加,该通路在炎症性疾病中起关键作用且已有特异性生物治疗。

核心结论

  • 多组学方法可揭示潜在临床可干预靶点用于个体化治疗。
  • 研究提供蛋白质基因组学分析流程,利用个体特异性基因组和转录组信息改进蛋白鉴定并推进个体化医学。

研究设计与样本

  • 研究结合外显子组、转录组和蛋白质组分析,对两名携带相同高IgD综合征纯合致病突变且表型相反的同胞进行分子层面表型差异解析。
  • 研究指出单组学(主要为外显子组)分析在人类复杂疾病中未能识别致病基因/突变时,多组学分析可能提供解决方案,但此前在临床环境中很少使用。

主要发现

  • 多组学方法识别出单个基因STAT1,其携带罕见错义变异,且在症状同胞较无症状同胞显示mRNA和蛋白显著过表达。
  • 该STAT1变异被证明为功能获得性,参与JAK/STAT信号通路激活增加。
  • 基于差异表达转录本和蛋白信息的通路分析证实STAT1在导致症状同胞炎症表型增加的调控网络中的核心作用。

关键数值与推荐

  • 症状同胞较无症状同胞STAT1的mRNA和蛋白显著过表达。
  • STAT1变异为罕见错义变异,功能获得性,参与JAK/STAT通路激活增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of the present study was to explain why two siblings carrying both the same homozygous pathogenic mutation for the autoinflammatory disease hyper IgD syndrome, show opposite phenotypes, that is, the first being asymptomatic, the second presenting all classical characteristics of the disease. METHODS: Where single omics (mainly exome) analysis fails to identify culprit genes/mutations in human complex diseases, multiomics analyses may provide solutions, although this has been seldom used in a clinical setting. Here we combine exome, transcriptome and proteome analyses to decipher at a molecular level, the phenotypic differences between the two siblings. RESULTS: This multiomics approach led to the identification of a single gene-STAT1-which harboured a rare missense variant and showed a significant overexpression of both mRNA and protein in the symptomatic versus the asymptomatic sister. This variant was shown to be of gain of function nature, involved in an increased activation of the Janus kinase/signal transducer and activator of transcription signalling (JAK/STAT) pathway, known to play a critical role in inflammatory diseases and for which specific biotherapies presently exist. Pathway analyses based on information from differentially expressed transcripts and proteins confirmed the central role of STAT1 in the proposed regulatory network leading to an increased inflammatory phenotype in the symptomatic sibling. CONCLUSIONS: This study demonstrates the power of a multiomics approach to uncover potential clinically actionable targets for a personalised therapy. In more general terms, we provide a proteogenomics analysis pipeline that takes advantage of subject-specific genomic and transcriptomic information to improve protein identification and hence advance individualised medicine.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Carapito R, Carapito C, Morlon A, et al. Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency. Ann Rheum Dis. 2018. PMID: 30030262. doi:10.1136/annrheumdis-2018-213524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。